Inicio>>Signaling Pathways>> DNA Damage/DNA Repair>> DNA/RNA Synthesis>>Madrasin

Madrasin (Synonyms: DDD00107587)

Catalog No.GC19238

Madrasin (DDD00107587) es un inhibidor de empalme que previene la formaciÓn de productos e intermedios de empalme in vitro e interfiere con uno o mÁs pasos tempranos en la vÍa de ensamblaje del spliceosoma. Madrasin también puede inhibir el empalme de pre-ARNm in vitro y modificar el empalme de pre-ARNm endÓgeno en las células.

Products are for research use only. Not for human use. We do not sell to patients.

Madrasin Chemical Structure

Cas No.: 374913-63-0

Tamaño Precio Disponibilidad Cantidad
5mg
44,00 $
Disponible
10mg
66,00 $
Disponible
25mg
133,00 $
Disponible
50mg
221,00 $
Disponible
100mg
369,00 $
Disponible

Tel:(909) 407-4943 Email: sales@glpbio.com

Reseñas de cliente

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

Madrasin is a potent and cell penetrant splicing inhibitor that interferes with the early stages of spliceosome assembly. Madrasin is cytotoxic at higher concentrations, although at lower concentrations it induces cell cycle arrest, promotes a specific reorganization of subnuclear protein localization, and modulates splicing of multiple pre-mRNAs in both HeLa and HEK293 cells.

References:
[1]. Andrea Pawellek et al. Identification of Small Molecule Inhibitors of Pre-mRNA Splicing. J Biol Chem, 2014 Dec 12, 289(50): 34683-34698.

Reseñas

Review for Madrasin

Average Rating: 5 ★★★★★ (Based on Reviews and 3 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Madrasin

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.